Trial intelligence / Profile preview

Yisaipu prefilled injection vs lyophilized powder in ankylosing spondylitis

CTR20130124Phase 3Completed

Sponsor
3S Guojian Pharmaceutical
Start
May 2014
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of etanercept in ankylosing spondylitis (AS), sponsored by 3S Guojian Pharmaceutical. Started May 2014; status: completed.

02

Drugs

etanercept
03

Conditions

ankylosing spondylitis (AS)

Beyond the preview

Go deeper on CTR20130124.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130124.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call